Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/2813938
Abstract: Homoharringtonine- (HHT-) based HHT, aclarubicin, and cytarabine (HAA) induction regimen is the first-line therapy for nonelder acute myeloid leukemia (AML) patients in China. However, drug resistance is a new challenge, and little attention has been…
read more here.
Keywords:
hht resistant;
resistance;
hht;
resistant cell ... See more keywords